Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up.
about
Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented peopleFolic acid with or without vitamin B12 for cognition and dementiaHomocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementationMethylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitusHomocysteine and ischaemic stroke in men: the Caerphilly studyHomocystein and carotid atherosclerosis in chronic renal failure.The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementiaThe use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys.Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Blood levels of homocysteine and atherosclerotic vascular disease.Diagnosis and treatment of hyperhomocysteinemia.Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literatureDietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol.Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.Low-grade systemic inflammation profile, unrelated to homocysteinemia, in obese children.Homocysteine and blood pressure.Thrombophilia and stroke.Homocysteine and cardiovascular disease in renal disease.Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.Suppression of homocysteine levels by vitamin B12 and folates: age and gender dependency in the Jackson Heart Study.Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.Therapeutical approach to plasma homocysteine and cardiovascular risk reduction.Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.Postgraduate Symposium: The MTHFR C677T polymorphism, B-vitamins and blood pressure.Novel biomarkers with potential for cardiovascular risk reclassification.Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by interfering with MAPK kinase pathway.Serum homocysteine does not associate with uncomplicated coronary heart disease.S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations.Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes.Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis: Role of vitamin E.Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis.Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations.Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with ischemic stroke.677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patients.
P2860
Q24240775-427558E8-A3AD-4A97-B9B2-23A406A1EE15Q24247785-48A3CE7E-C30E-4746-B3F2-F1E347B36555Q24791545-CA49491E-D5C8-4169-ABEF-8222BEB1BBEBQ28274776-1568EBD6-7313-4C01-BFD0-2790CF5483E6Q28345707-04B6E80B-F490-4E24-859A-0430D3841494Q30488450-B815FD10-D201-405C-B0FA-30B63FB8FF1CQ31129827-01CCC7E2-7D32-4B4C-B3B7-84B9628CA867Q33583592-CD217DBD-3ECF-4D98-8C78-1A6CFA265BB1Q33898462-2A0571DB-8DD4-4BC6-9078-081D21F17E96Q34038098-34B2DF9F-63CC-4A55-B302-114F35D1B351Q34107404-808B0A09-90A3-4637-BA81-9855223F7139Q34109461-A8C3C8A0-9F00-4607-992E-F4C9DE2E7F11Q34121446-73DCFDBA-3181-4DC2-9C2C-6EEF5E952D4EQ34402922-B4FA6F0B-E521-49F6-9284-B8B2FEE9A77FQ34577250-C4C9F0A6-A2BE-451B-A2DF-C2E0202B1897Q34890689-3F18F738-995C-460B-87C2-36DE6CD08DF6Q34945453-575B34DD-7E0A-4146-9DCE-7C768E652652Q35046487-9DB98FF7-AFD1-4DDF-8EC8-9038BF47BBD5Q35610110-ECF736B1-1D59-46FD-8C4F-DACD67F166D2Q35687622-A49D76AF-B7EF-44ED-A34F-F4FC7D20E53DQ35737842-CAA9BE54-8666-492A-A90A-F3E88D352B12Q35870635-98746692-BF45-45DD-B2A5-46AD483982C5Q36443604-2C013427-003D-4D5D-961C-70F46A2186F7Q36548650-88FA1D22-B693-4C9B-8CF1-C1170D69F8FBQ36822904-53483718-4605-4577-B031-8DD1BC8477E6Q37299480-ED8F82B8-58D5-4293-AD86-D4511BBAEF47Q37642915-84EC06CB-3432-45D5-B358-C2CC93CDA80BQ38864815-3B3EEAB1-C73A-4BE0-9078-AEDAFBBD66E5Q40332063-4A11E9B9-5C76-4F49-8098-16D67B07B8B7Q43674602-D68F719D-3680-423C-83EF-C0C0EB17075CQ44256199-A1C4D680-C2E8-426B-A90E-AA0221EECD70Q44286470-753413E1-CB12-45D5-879B-79045EE07859Q44326347-69A50B32-3961-446F-BEDE-45243057CFD2Q44752589-135676CF-DF6E-4B75-8322-4EF7FD9D7FEFQ45135207-B646DC88-2042-4C42-8AF0-5CD36481394FQ45220629-4742F9B6-4CEC-4B21-8E9D-145B04857C42Q45240512-E774F912-3606-48DB-ADF0-73BB5B7B71EEQ46932482-80E46596-B3E0-4CD9-A9A1-717AE1FDFE49Q46953181-CCC5B358-660C-42E4-9218-68D0EE26A8E0Q48209997-41950BDA-CAF2-4C77-B2EE-E93B71883B8A
P2860
Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@en
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@nl
type
label
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@en
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@nl
prefLabel
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@en
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@nl
P2093
P1476
Serum homocysteine and risk of ...... erly men: a 10-year follow-up.
@en
P2093
Feskens EJ
Kromhout D
Stehouwer CD
Weijenberg MP
van den Berg M
P304
P356
10.1161/01.ATV.18.12.1895
P407
P577
1998-12-01T00:00:00Z